Immix Biopharma

(NASDAQ) IMMX

Current Price$9.28

Market Cap$493.01M

Since IPO (2021)+153%

5 YearN/A

1 Year+356%

1 Month+8%

Immix Biopharma Financials at a Glance

Market Cap

$493.01M

Revenue (TTM)

$0.00

Net Income (TTM)

$29.44M

EPS (TTM)

$-0.89

P/E Ratio

-10.44

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$9.28

Volume

26,669

Open

$8.98

Price

$9.28

Volume

26,669

Open

$8.98

Previous Close

$9.28

Daily Range

$8.86 - $9.45

52-Week Range

$1.87 - $11.61

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$9.28

Volume

26,669

Open

$8.98

Previous Close

$9.28

Daily Range

$8.86 - $9.45

52-Week Range

$1.87 - $11.61

IMMX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immix Biopharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Ilya Rachman, MD, PhD

Website

www.immixbio.com

Headquarters

Los Angeles, CA 90064, US

IMMX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-55%

Return on Capital

-32%

Return on Assets

-28%

Earnings Yield

-9.58%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$493.01M

Shares Outstanding

53.01M

Volume

26.67K

Avg. Volume

777.43K

Financials (TTM)

Gross Profit

$364.50K

Operating Income

$27.21M

EBITDA

$26.85M

Operating Cash Flow

$23.93M

Capital Expenditure

$732.92K

Free Cash Flow

$24.66M

Cash & ST Invst.

$100.41M

Total Debt

$1.07M

Immix Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$90.63K

N/A

Gross Margin

0.00%

N/A

Market Cap

$493.01M

N/A

Market Cap/Employee

$27.39M

N/A

Employees

N/A

Net Income

$10.69M

-122.1%

EBITDA

$10.80M

-118.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$99.34M

+498.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$933.63K

-7.5%

Short Term Debt

$139.34K

+113.6%

Return on Assets

-28.08%

N/A

Return on Invested Capital

-31.62%

N/A

Free Cash Flow

$11.19M

-464.4%

Operating Cash Flow

$11.03M

-647.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ZNTLZentalis Pharmaceuticals, Inc.

ZNTLZentalis Pharmaceuticals, Inc.$4.09+2.00%

SRZNSurrozen, Inc.

SRZNSurrozen, Inc.$33.60+0.60%

MGNXMacroGenics, Inc.

MGNXMacroGenics, Inc.$3.13+1.62%

WHWKWhitehawk Therapeutics Inc

WHWKWhitehawk Therapeutics Inc$3.99-0.50%

ORMPOramed Pharmaceuticals Inc.

ORMPOramed Pharmaceuticals Inc.$3.98+2.58%

ONCYOncolytics Biotech Inc.

ONCYOncolytics Biotech Inc.$0.87-1.13%

PLRXPliant Therapeutics, Inc.

PLRXPliant Therapeutics, Inc.$1.20-1.64%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About IMMX

What is the current price of Immix Biopharma?

Immix Biopharma is trading at $9.28 per share.

What is the 52-week range for Immix Biopharma?

Over the past 52 weeks, Immix Biopharma has traded between $1.87 and $11.61.

How much debt does Immix Biopharma have?

As of the most recent reporting period, Immix Biopharma reported total debt of $1.07M.

How much cash does Immix Biopharma have on hand?

Immix Biopharma reported $93.93M in cash and cash equivalents in its most recent financial results.

What is Immix Biopharma’s dividend yield?

Immix Biopharma does not currently have a dividend yield.

Immix Biopharma

Immix Biopharma Financials at a Glance

IMMX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Immix Biopharma

IMMX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Immix Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMMX

What is the current price of Immix Biopharma?

What is the 52-week range for Immix Biopharma?

How much debt does Immix Biopharma have?

How much cash does Immix Biopharma have on hand?

What is Immix Biopharma’s dividend yield?

Premium Investing Services